<p>The optimal surgical treatment for lateral epicondylitis remains debated, while arthroscopic lateral release offers theoretical benefits over the traditional open approach. This study aimed to compare arthroscopic versus open technique in early and long-term outcomes. In this study, 45 patients with chronic lateral epicondylitis underwent arthroscopic (<i>n</i> = 23) and open lateral release (<i>n</i> = 22). The primary outcome was the Patient-Rated Tennis Elbow Evaluation (PRTEE) score. Secondary outcomes included the visual analog scale (VAS) for pain, Quick Disabilities of the Arm, Shoulder, and Hand (qDASH) score, time to return to work, operative time, scar satisfaction, and complications from postoperative day 1 through 12&#xa0;months. Both surgical techniques significantly improved pain and function without complications at 12&#xa0;months. However, the arthroscopic group demonstrated superior early outcomes. At 1&#xa0;month, PRTEE scores were significantly lower in the arthroscopic group (mean 0.47 ± 0.10 vs. 0.75 ± 0.10; <i>P</i> &lt; 0.05). VAS score was markedly reduced from day 1 through 1&#xa0;month (<i>P</i> &lt; 0.05), with a mean day 1 difference of −2.7 (95% CI −2.90 to −2.03). qDASH scores also favored arthroscopy at week 1 (mean 13.2 vs. 21.3; <i>P</i> &lt; 0.05), returned to full-duty work significantly earlier (mean 2.3 vs. 12.9&#xa0;weeks; <i>P</i> &lt; 0.05), and reported higher scar satisfaction (mean 5.0 vs. 4.63; <i>P</i> &lt; 0.05). The open technique had significantly shorter operative time (30.5 vs. 40.6&#xa0;min.; <i>P</i> &lt; 0.05). Both surgical techniques are effective and safe. The arthroscopic approach had significant early advantages, including reduced pain, quicker return to work, and superior cosmetic satisfaction. These findings support arthroscopic release as a preferred option for patients prioritizing early recovery and minimal invasiveness.</p><p><b>Level of Evidence </b>Level I.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Comparative Efficacy of Arthroscopic and Open Lateral Release for Lateral Epicondylitis: A Randomized Trial Assessing Pain, Function, and Recovery

  • Patarapon Inthawong,
  • Jaruwat Vechasilp,
  • Thanapol Wangrattanapranee,
  • Wisaroot Harnboonseth,
  • Jirantanin Rattanavarinchai,
  • Lertkong Nitiwarangkul,
  • Woraphon Jaroenporn

摘要

The optimal surgical treatment for lateral epicondylitis remains debated, while arthroscopic lateral release offers theoretical benefits over the traditional open approach. This study aimed to compare arthroscopic versus open technique in early and long-term outcomes. In this study, 45 patients with chronic lateral epicondylitis underwent arthroscopic (n = 23) and open lateral release (n = 22). The primary outcome was the Patient-Rated Tennis Elbow Evaluation (PRTEE) score. Secondary outcomes included the visual analog scale (VAS) for pain, Quick Disabilities of the Arm, Shoulder, and Hand (qDASH) score, time to return to work, operative time, scar satisfaction, and complications from postoperative day 1 through 12 months. Both surgical techniques significantly improved pain and function without complications at 12 months. However, the arthroscopic group demonstrated superior early outcomes. At 1 month, PRTEE scores were significantly lower in the arthroscopic group (mean 0.47 ± 0.10 vs. 0.75 ± 0.10; P < 0.05). VAS score was markedly reduced from day 1 through 1 month (P < 0.05), with a mean day 1 difference of −2.7 (95% CI −2.90 to −2.03). qDASH scores also favored arthroscopy at week 1 (mean 13.2 vs. 21.3; P < 0.05), returned to full-duty work significantly earlier (mean 2.3 vs. 12.9 weeks; P < 0.05), and reported higher scar satisfaction (mean 5.0 vs. 4.63; P < 0.05). The open technique had significantly shorter operative time (30.5 vs. 40.6 min.; P < 0.05). Both surgical techniques are effective and safe. The arthroscopic approach had significant early advantages, including reduced pain, quicker return to work, and superior cosmetic satisfaction. These findings support arthroscopic release as a preferred option for patients prioritizing early recovery and minimal invasiveness.

Level of Evidence Level I.